Top Markets
Coin of the day
Voronoi, Inc. Voronoi, Inc.

Voronoi, Inc.

310210
Classificação em ações #6297
Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a... Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a biotechnology company dedicated to the research, development, and identification of small molecule kinase inhibitors. Its extensive product pipeline addresses various medical needs. Key candidates include VRN01, an oral leucine-rich repeat kinase 2 (LRRK2) inhibitor, being developed for glioblastoma multiforme, brain cancer, and pancreatic cancer. Treatments for lung cancer are represented by VRN07, VRN06, and VRN11, while VRN08 and VRN10 are in development for breast cancer. Additionally, VRN02 targets rheumatoid arthritis and atopic dermatitis. The company's pipeline further encompasses VRN04-1 for autoimmune conditions, VRN04-2 for multiple sclerosis and amyotrophic lateral sclerosis (ALS), VRN13 for pulmonary arterial hypertension, and VRN14 for challenging solid tumors.
Preço da ação
$115.48
Valor de mercado
$2.12B
Variação (1 dia)
0.72%
Variação (1 ano)
29.38%
País
KR
Negociar Voronoi, Inc. (310210)

Categoria

Histórico de preços das ações de Voronoi, Inc. (310210)
Preço de fecho mais alto: $117.55 em 2026-08-01

Preço de fecho mais baixo: $21.91 em 2022-06-01
Histórico de preços das ações da Voronoi, Inc. de 2022 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 0.57%
2025 181.09%
2024 62.84%
2023 71.45%
2022 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$548.36 40.94%
US
$1.06K 49.46%
NL
$122.63 -12.65%
AU
$140.81 461.00%
US
$765.25 7.19%
CH